Par Sterile Products

Par Sterile Products, a subsidiary of Endo, is a leading developer and manufacturer of sterile injectable pharmaceuticals. The company specializes in a broad portfolio of branded and generic injectable products across various therapeutic areas, including critical care, oncology, and anti-infectives. Its flagship products include Vasostrict and Adrenalin, which are widely used in hospital settings. Operating primarily out of its state-of-the-art facility in Rochester, Michigan, the company provides both proprietary drug development and contract manufacturing services. Par Sterile Products was formed following Par Pharmaceutical's acquisition of JHP Pharmaceuticals in 2014. The company maintains a strong focus on high-barrier-to-entry products and complex formulations.